SpletThe 8-hour buprenorphine waiver training is offered in a ‘half- and-half’ format - 4 hours of in-person or virtual training followed up by 4 hours of online training through PCSS. Upon … Splet29. mar. 2024 · Removal of DATA Waiver (X-Waiver) Requirement. Section 1262 of the Consolidated Appropriations Act, 2024 (also known as Omnibus bill), removes the federal …
PCSS Learning: Product Catalog :: American Academy of …
SpletA DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder. Going forward, all prescriptions for buprenorphine only require a standard DEA registration number. The previously used DATA-Waiver registration numbers are no longer needed for any prescription. SpletThese training presentations consist of PCSS’ data waiver training curriculum, for a total of 8 hours. Modules include: 1. Overview 2. Neurobiology 3. Pharmacology 4. Patient Evaluation 5. Specialty Topics 6. Medication Assisted treatment (MAT) and Urine Drug Testing 7. Evidence-based Counseling 8. Clinical Management Materials deadline of 1601eq 3rd quarter 2022
Removal of DATA Waiver (X-Waiver) Requirement SAMHSA
SpletPCSS is a national training and clinical mentoring project developed in response to the opioid use disorder crisis. The overarching goal of PCSS is to provide the most effective evidenced-based clinical practices in the prevention, identification, and treatment of opioid use disorders. Log In Create Account Home Catalog Cart (0 items) Splet11. apr. 2024 · Providers Clinical Support System (PCSS): Buprenorphine Training for Advanced Practice Registered Nurses (APRN) ... Removal of DATA Waiver (X-Waiver) Requirement. Section 1262 of the Consolidated Appropriations Act, 2024 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of … Splet13. jan. 2024 · Removal of DATA Waiver (X-Waiver) Requirement - AAAP. January 13, 2024. Section 1262 of the Consolidated Appropriations Act, 2024 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use … deadline of 1701q 3rd quarter 2022